Liam C. Lee

A Combination RNAi-Chemotherapy Layer-by-Layer Nanoparticle for Systemic Targeting of KRAS/P53 with Cisplatin to Treat Non–Small Cell Lung Cancer

Prediction of potent shRNAs with a sequential classification algorithm

Cancer nanomedicine: progress, challenges and opportunities

The biology and function of fibroblasts in cancer

Shedding light on the cell biology of extracellular vesicles

Copper is an essential regulator of the autophagic kinases ULK1/2 to drive lung adenocarcinoma

PROTAC targeted protein degraders: the past is prologue

Exosomes facilitate therapeutic targeting of oncogenic KRAS in pancreatic cancer

Specificities of secretion and uptake of exosomes and other extracellular vesicles for cell-to-cell communication

Refined sgRNA efficacy prediction improves large- and small-scale CRISPR–Cas9 applications

Clinical experiences with systemically administered siRNA-based therapeutics in cancer

Liposomal Formulations in Clinical Use: An Updated Review

Ionizable lipid nanoparticles deliver mRNA to pancreatic β cells via macrophage-mediated gene transfer

Copper induces cell death by targeting lipoylated TCA cycle proteins

The biology , function , and biomedical applications of exosomes

A recombinant chimeric protein specifically induces mutant KRAS degradation and potently inhibits pancreatic tumor growth

EMT, CTCs and CSCs in tumor relapse and drug-resistance

Development of siRNA Payloads to Target KRAS -Mutant Cancer

MAP kinase and autophagy pathways cooperate to maintain RAS mutant cancer cell survival

CRIPTO1 expression in EGFR-mutant NSCLC elicits intrinsic EGFR-inhibitor resistance